IRIDEX CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-07-04 was 0.00 shares.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-04-04 was 0.00 shares.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-28 was 0.00 shares.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-29 was 0.00 shares.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 2.01K shares, a 94.69% decline from fiscal 2023.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 37.84K shares, a 290.41% increase from fiscal 2022.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 9.69K shares, a 85.37% decline from fiscal 2022.
- IRIDEX CORP share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 66.23K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-07-04 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-18 | |
| 2026-04-04 | 0.00 shares 10-Q · filed 2026-05-19 | |
| 2025-06-28 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-18 | 1.88K shares derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-03-29 | 0.00 shares 10-Q · filed 2026-05-19 | |
| 2024-12-28 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-02 | 2.01K shares 10-K · filed 2026-04-02 |
| 2024-09-28 | 1.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2023-12-30 | 20.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 37.84K shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | 17.50K shares derived: sum of 4 quarters · filed 2024-03-29 |
| 2023-07-01 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | |
| 2023-04-01 | 17.50K shares 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 9.69K shares 10-K · filed 2024-03-29 |
| 2022-04-02 | 6.06K shares 10-Q · filed 2022-05-12 | 69.22K shares derived: sum of 4 quarters · filed 2023-03-09 |
| 2022-01-01 | 13.01K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 66.23K shares 10-K · filed 2023-03-09 |
| 2021-10-02 | 29.92K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | |
| 2021-07-03 | 20.22K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2021-04-03 | 3.08K shares 10-Q · filed 2021-05-12 | |
| 2019-12-28 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | 210.00 shares 10-K · filed 2021-03-23 |
| 2019-09-28 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 510.00 shares derived: sum of 4 quarters · filed 2020-03-13 |
| 2019-06-29 | 2.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 8.01K shares derived: sum of 4 quarters · filed 2020-03-13 |
| 2019-03-30 | 208.00 shares 10-Q · filed 2019-05-07 | 18.01K shares derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-12-29 | 300.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 24.05K shares 10-K · filed 2020-03-13 |
| 2018-09-29 | 7.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 32.38K shares derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-06-30 | 10.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 40.26K shares derived: sum of 4 quarters · filed 2019-03-29 |
| 2018-03-31 | 6.25K shares 10-Q · filed 2018-05-08 | 43.18K shares derived: sum of 4 quarters · filed 2019-03-29 |
| 2017-12-30 | 8.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | 64.38K shares 10-K · filed 2019-03-29 |
| 2017-09-30 | 15.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 64.25K shares derived: sum of 4 quarters · filed 2018-03-14 |
| 2017-07-01 | 12.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | 78.03K shares derived: sum of 4 quarters · filed 2018-03-14 |
| 2017-04-01 | 27.45K shares 10-Q · filed 2017-05-09 | 100.02K shares derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-12-31 | 8.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | 126.08K shares 10-K · filed 2018-03-14 |
| 2016-10-01 | 29.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | 189.37K shares derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-07-02 | 34.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | 198.96K shares derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-04-02 | 53.50K shares 10-Q · filed 2016-05-09 | 205.11K shares derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-01-02 | 71.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | 277.73K shares 10-K · filed 2018-03-14 |
| 2015-10-03 | 38.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | 308.87K shares derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-07-04 | 41.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 356.97K shares derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-04-04 | 126.12K shares 10-Q · filed 2015-05-12 | 441.21K shares derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-01-03 | 102.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | 399.39K shares 10-K · filed 2017-03-15 |
| 2014-09-27 | 86.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-03 | 416.42K shares derived: sum of 4 quarters · filed 2016-03-31 |
| 2014-06-28 | 125.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | 411.22K shares derived: sum of 4 quarters · filed 2016-03-31 |
| 2014-03-29 | 84.30K shares 10-Q · filed 2014-05-05 | 462.97K shares derived: sum of 4 quarters · filed 2016-03-31 |
| 2013-12-28 | 119.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-31 | 493.62K shares 10-K · filed 2016-03-31 |
| 2013-09-28 | 81.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | 393.64K shares derived: sum of 4 quarters · filed 2015-04-02 |
| 2013-06-29 | 177.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05 | 330.56K shares derived: sum of 4 quarters · filed 2015-04-02 |
| 2013-03-30 | 114.96K shares 10-Q · filed 2013-05-06 | |
| 2012-12-29 | 19.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-02 | 174.63K shares 10-K · filed 2015-04-02 |
| 2012-09-29 | 18.57K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | |
| 2011-12-31 | 99.29K shares 10-K · filed 2014-03-27 | |
| 2011-01-01 | 34.56K shares 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |